Clinical trial NCT04619784: Effect of Pilates Application on Abdominal Muscle Function, Core Stability, Musculoskeletal Pain, Quality of Life, Anxiety and Depression in Parkinson's Patients
Official title: The Effect of Pilates Application on Abdominal Muscle Function, Core Stability, Musculoskeletal Pain, Quality of Life, Anxiety and Depression in Parkinson's Patients
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Parkinson Disease
Pilates
Muscle Function
Lead sponsor: Dokuz Eylul University
Sponsor class: OTHER
First posted: 2020-11-06
Enrollment: 20
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NON_RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: In this study, it is aimed to investigate the effect of Pilates application on abdominal muscle function, core stability, musculoskeletal pain, quality of life, anxiety and depression in Parkinson's Patients.

Detailed description: Objective: In this study, it is aimed to investigate the effect of Pilates application on abdominal muscle function, core stability, musculoskeletal pain, quality of life, anxiety and depression in Parkinson's Patients.

Method: The study included 15 Idiopathic Parkinson's Patients over 18 years of age, under stage 3 according to the Hoehn-Yahr clinical staging. Patients were divided into intervention and control groups. Pilates training was performed for 6 weeks, twice a week and 60 minutes per session in intervention group. Demographic features will be questioned and recorded in the data recording form through mutual interview in patients who meet the inclusion criteria; evaluations will be made regarding muscle thickness and pain. All patients will be evaluated before treatment, after treatment, at the 3rd and 6th months.

Eligibility criteria: Inclusion Criteria:

* Diagnosed with Idiopathic Parkinson's Disease
* Must be older 18 years old
* Must have 24 and above score on Mini Mental Test
* Must be the third or lower stage according to the Hoehn-Yahr staging
* Must have stable clinical status

Exclusion Criteria:

* Musculoskeletal or cognitive impairment at a level affecting evaluation and treatment
* Other neurological disease

Primary outcomes:
measure: Muscle Function
timeFrame: Patients will be evaluated before treatment, 1 week after treatment, at the 3rd and 6th months after treatment
Secondary outcomes:
measure: Core stability
timeFrame: Patients will be evaluated before treatment, 1 week after treatment, at the 3rd and 6th months after treatment
measure: Musculoskeletal Pain
timeFrame: Patients will be evaluated before treatment, 1 week after treatment, at the 3rd and 6th months after treatment
measure: Quality of Life
timeFrame: Patients will be evaluated before treatment, 1 week after treatment, at the 3rd and 6th months after treatment
measure: Anxiety
timeFrame: Patients will be evaluated before treatment, 1 week after treatment, at the 3rd and 6th months after treatment
measure: Pain intensity
timeFrame: Patients will be evaluated before treatment, 1 week after treatment, at the 3rd and 6th months after treatment
measure: Depression
timeFrame: Patients will be evaluated before treatment, 1 week after treatment, at the 3rd and 6th months after treatment.
Other outcomes:
Locations:
city: İzmir
country: Turkey
facility: Dokuz Eylul University
Study officials:
References: